BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Milestone For Vapourtec R-Series Flow Chemistry System


2/18/2014 9:36:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

February 18, 2014 -- Chemistry engineering specialists Vapourtec (Suffolk, UK) has seen its flagship R-Series flow chemistry system reach a notable milestone with global sales recently reaching the 200 mark.

The R-Series has a wide range of applications and is already used around the world by many major companies including BP, Pfizer, GSK, Sanofi, Novartis and Johnson & Johnson.

The 200th system was purchased by the University of Manitoba, based at Winnipeg in Canada. Assistant Professor Geoff Tranmer PhD from their Faculty of Pharmacy is no stranger to Vapourtec’s technology having first used the R-Series system whilst at Cambridge University in 2006.

Geoff Tranmer commented: “I feel the R-Series' robust performance, accessible usability and flexibility will genuinely enhance my group's ability to develop innovative flow chemistry techniques and allow us to make many breakthroughs in pharmaceutical research as a result.

“Vapourtec’s ability to make design and engineering innovations in terms of complementary add-ons and expansion modules have enabled the R-Series to stay ahead of the game,” added Geoff.

Vapourtec’s founder and MD Duncan Guthrie commented: “The R-Series system was launched in 2006 with the aim of making flow chemistry, a fast growing alternative to batch chemistry, more flexible, precise and ultimately productive.

“It has impacted positively on flow chemistry research in a wide range of industries and fields covering petrochemicals, flavourings, pharmaceuticals, generic drug manufacture, polymers and organic electronics.

“Already cited as pivotal within 110 published research papers, the R-Series is one of two flow chemistry systems designed and manufactured by Vapourtec with the E-Series launched in 2013.

“We are delighted that Geoff has helped us reach the 200 landmark as it demonstrates the loyalty and trust that the R-Series has elicited within chemistry research,” added Duncan.

Vapourtec design and manufacture flow chemistry systems for a wide variety of sectors across the globe including education, pharmaceutical and industry and their technology has been cited as playing a pivotal part in recent major research breakthroughs.

Established in 2003, Vapourtec has developed a flourishing international market for its technology with sales across much of the developed world including USA, Canada, China, Japan, Singapore and India.

For more details visit www.vapourtec.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Vapourtec
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES